Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Apnea, Obstructive 1Radiation Injuries 1Lymphoma, Follicular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 38Radiotherapy, Intensity-Modulated 12Cisplatin 12Amifostine 11Paclitaxel 7Carboplatin 7Radiosurgery 6Etoposide 5Brachytherapy 5Surgical Procedures, Operative 4Low-Level Light Therapy 4Donepezil 4Chemotherapy, Adjuvant 4Bevacizumab 4sargramostim 3Surveys and Questionnaires 3Radiation 3Proton Therapy 3Neuropsychological Tests 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Heavy Ion Radiotherapy 3Filgrastim 3Diet Therapy 3Chemoradiotherapy 3Blood Specimen Collection 3Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Lithium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Mometasone Furoate × Clear all
NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Alliance for Clinical Trials in Oncology

Phase 3 Completed
176 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡